HIGHLIGHTS
- who: Rahim Hirani from the NY, USA have published the research work: Monkeypox outbreak in the age of COVID-19: a new global health emergency, in the Journal: (JOURNAL)
SUMMARY
Whilst combating the psychological burden associated with the treatment of diseases such as COVID-19 and monkeypox poses a systemic challenge for institutions and will likely be a long-term effort-the clinical component also presents a uniquely challenging perspective. Tecovirimat has previously been approved in accordance with the Food and Drug Administration (FDA) Animal Rule for treatment of smallpox, by using non . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.